The global real-world evidence solutions market is on the brink of an extraordinary expansion, with market value expected to soar from USD 42.8 billion in 2022 to an impressive USD 110 billion by 2032. According to Future Market Insights, the market is projected to grow at a Compound Annual Growth Rate (CAGR) of 10%, significantly surpassing the previous average CAGR of 8.6%, underscoring the sector’s robust growth trajectory.
This surge, amounting to a financial upswing of USD 67.2 billion over the next decade, is driven by the increasing adoption of real-world evidence solutions across the healthcare landscape. RWE solutions are now recognized as essential tools in optimizing healthcare decision-making processes, enhancing clinical trials, and improving patient outcomes. These advancements are fueling demand from stakeholders across the healthcare industry, including pharmaceutical companies, healthcare providers, and regulatory bodies.
Real-World Data Revolutionizing Healthcare Decision-Making
Real-world evidence solutions leverage real-world data to provide healthcare stakeholders with actionable insights, enabling evidence-based strategies to enhance patient care and streamline healthcare practices. These solutions are increasingly integral in informing regulatory decisions, optimizing healthcare delivery, and driving operational efficiency across the industry.
Key Market Segments Experiencing Robust Growth
Several key segments within the RWE solutions market are witnessing significant adoption. Electronic health records, claims and billing data, and patient registries are at the forefront, offering comprehensive, real-time insights into patient populations and treatment outcomes. Their instrumental role in advancing healthcare practices is driving their rapid growth.
Technological Advancements Driving Market Innovation
The market’s upward trajectory is further supported by advancements in analytics and artificial intelligence (AI). These technological innovations are revolutionizing data analysis, fostering the development of sophisticated real-world evidence solutions with enhanced insights and predictive capabilities.
Shaping the Future of Healthcare
The evolving landscape of the real-world evidence solutions market underscores its pivotal role in transforming healthcare. As the market continues to expand at an unprecedented rate, stakeholders across the healthcare spectrum are positioned to leverage the transformative potential of real-world evidence to drive progress and innovation.
Key Takeaways from the Market Study:
- The market is predicted to develop at a 10% CAGR, which is much higher than the 8.6% CAGR recorded in the past.
- The global market for Real World Evidence Solutions will be worth USD 110 billion by the end of 2032.
- The market is estimated to offer an absolute dollar opportunity of USD 67.2 billion between 2022 and 2032.
- With a CAGR of 10.4%, the services segment leads the development among components.
- The US market for Real World Evidence Solutions accounts for 29.9% of the global market. During the anticipated period of 2022 to 2032, it is expected to expand at a CAGR of 11.2%.
- Drug Development and Approvals segment tops among the applications. Revenue through this segment is expected to grow at a CAGR of 10% during the forecast period.
Due to the pandemic induced business disruptions, companies were unable to undertake on-site surveillance or deliver services that required one to one interactions. This prompted the market players to implement several cost-cutting measures and business continuity tactics to allow remote access and monitoring of patients, comments a Future Market Insights analyst.
Surge in Market Demand: Explore Comprehensive Trends and Analysis in Our Full Report!
Competitive Landscape:
The Real World Evidence Solutions Market is driven by the Market players who are expanding their product portfolios by highly investing in the R&D and Product development areas. Furthermore, to retain their dominance in global market they are expanding by means of strategic mergers and acquisitions and creating the market presence in the untapped market across the globe. They are anticipated to take advantage of the increased awareness, improved infrastructure and increased regulatory approvals for the RWE solutions.
The key competitors in the Real World Evidence Solutions Market are:
- Cegedim Health Data
- IBM
- Icon Plc.
- IQVIA
- Medpace
- Oracle
- Parexel International Corp.
- PerkinElmer, Inc.
- PPD, Inc.
- Syneos Health
Market Segments Covered in Real World Evidence Solutions Market Study:
By Component:
- Services
- Data Sets
- Clinical Settings Data
- Claims Data
- Pharmacy data
- Patient-powered Data
By Application:
- Reimbursement/Coverage & Regulatory Decision Making
- Drug Development & Approvals
- Medical Device Development & Approvals
- Post Market Safety & Adverse Events Monitoring
By End-user:
- Healthcare payers
- Pharmaceutical & Medical Device Companies
- Healthcare Providers
- Other End-users
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
